Healthcare >> CEO Interviews >> March 22, 1999

Martin Barkin – Draxis Health Inc (draxf)

MARTIN BARKIN, MD, BScMed, MA, FRCSC, is the President and Chief Executive Officer of DRAXIS Health Inc., a public, Canadian pharmaceutical marketing and R&D company. He also serves on the Boards of Novopharm Biotech Inc. and Bone Care International Inc., and is Chairman of the Board of the Sunnybrook & Women's College Health Sciences Centre. Dr. Barkin came to DRAXIS (1992) from KPMG where he was Partner and National Practice Leader for Health Care (1991-1992). Before that, he was Deputy Minister of Health for the Province of Ontario (1987-1991), Secretary of the Premier's Council on Health and Chair of the Deputies' Cabinet Committee on Social Policy for the Province of Ontario. He holds the rank of Professor in the Faculty of Medicine at the University of Toronto in both the Departments of Surgery (1982-to date) and Health Administration (1984-to date). Dr. Barkin was President and C.E.O. of Sunnybrook Health Sciences Centre (1984-1987), a 1400-bed teaching and research centre, at which time he was also Vice- Chair of the Ontario Hospital Association and President of the Ontario Council of Teaching Hospitals. He was a practicing Urologist, Chief of the Division of Urology, Sunnybrook Health Sciences Centre (1972-1984), and a researcher, serving as Project Director at the Research Institute of the Hospital for Sick Children (1968-1992), and a member of Grants Review Committees of the Medical Research Council of Canada. Sector - Pharmaceutical Profile
TWST: Could you begin by giving us a historical review of Draxis Health

as well as how you see your company today?

Dr. Barkin: From its roots as a one-drug company confined to Canada